The brokerage praised the company’s “differentiated” AI-driven technology and its roadmap to achieve net profit positivity by the end of 2027.

Shares of digital insurer Lemonade, Inc. ($LMND) surged over 6% in pre-market trading Wednesday, positioning the stock to hit near three-year highs if the momentum holds. 

Add Asianet Newsable as a Preferred SourcegooglePreferred

The rally follows an upgrade from Morgan Stanley, which raised its rating on LMND to ‘Equal Weight’ from ‘Underweight’ and boosted the price target to $42 from $23, citing optimism about the company’s long-term growth potential after its recent investor day event.

Morgan Stanley said Lemonade has "charted an ambitious goal" to grow its gross earned premiums (GEP) from $1 billion to $10 billion over the coming years. 

The brokerage praised the company’s “differentiated” AI-driven technology and its roadmap to achieve net profit positivity by the end of 2027 — well ahead of consensus estimates.

An illustrative slide from Lemonade’s investor presentation reportedly suggested a potential valuation of $90 per share, assuming a 30% compound annual growth rate in GEP and a 12% adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio over seven years. 

That projection implies a 125% upside from the previous session’s close of just over $40.

LMND sentiment and message volume on Nov 20 as of 7:30 am ET | source: Stocktwits

On Stocktwits, retail sentiment mirrored the market’s enthusiasm, with the score flipping into the ‘extremely bullish’ zone pre-market. 

Discussions about Lemonade spiked significantly, reflecting renewed optimism around the stock’s future prospects.

Last month, Lemonade reported third-quarter revenue of $136.6 million, up 19% year-over-year, driven by increases in premiums and investment income. 

While its adjusted EBITDA loss widened to $49 million from $40.2 million a year earlier due to growth-related spending, the company’s per-share loss of $0.95 came in better than the expected $1.00.

LMND shares have gained over 135% year-to-date, outperforming broader market indices as investors increasingly bet on the company’s disruptive approach to the insurance industry.